Abbott Laboratories: F. Hoffman-La Roche Ltd.: D. Boehringer Ingelheim: D+. If the nine major HIV drug companies were in school, most would probably be in detention, according to a new "report card" issued by the AIDS Treatment Activists Coalition (ATAC). ATAC graded the drug companies in five different categories, including fair pricing and their relationship with the HIV community. Some did alright -- Merck & Co. and Tibotec Therapeutics both got B's -- but most didn't fare as well. In this one-on-one interview, we get the nitty-gritty on this telling report from longtime HIV/AIDS journalist and activist Bob Huff, a member of ATAC's board of directors.